Application Nr Approved Date Route Status External Links
ANDA208813 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Toremifene Citrate Tablets Are An Estrogen Agonist/antagonist Indicated For The Treatment Of Metastatic Breast Cancer In Postmenopausal Women With Estrogen-Receptor Positive Or Unknown Tumors. Toremifene Citrate Tablets Are An Estrogen Agonist/antagonist Indicated For The Treatment Of Metastatic Breast Cancer In Postmenopausal Women With Estrogen-Receptor Positive Or Unknown Tumors.(1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Toremifene Citrate TOREMIFENE CITRATE ZINC895081

Comments